>AT1G51910.1 |  protein kinase family protein 
MKTMNGFLLLSTIAFAVFHLVQAQSQSGFISLDCGLIPKDTTYTEQITNITYISDADYID 
SGLTERISDSYKSQLQQQTWTLRSFPEGQRNCYNFNLKANLKYLIRGTFVYGNYDGLNQM 
PKFDLHIGPNKWTSVILEGVANATIFEIIHVLTQDRLQVCLVKTGQTTPFISSLELRPLN 
NDTYVTQGGSLMSFARIYFPKTAYFLRYSDDLYDRVWVPFSQNETVSLSTNLPVDTSSNS 
YNVPQNVANSAIIPAEATHPLNIWWDLQNINAPSYVYMHFAEIQNLKANDIREFNITYNG 
GQVWESSIRPHNLSITTISSPTALNSSDGFFNFTFTMTTTSTLPPLINALEVYTLVENLL 
LETYQDEVSAMMNIKKTYGLSKKISWQGDPCSPQIYRWEGLNCLYLDSDQPLITSLNLRT 
SGLTGIITHDISNLIQLRELDLSDNDLSGEIPDFLADMKMLTLVNLKGNPKLNLTVPDSI 
KHRINNKSLKLIIDENQSSEKHGIKFPLVAILASVAGVIALLAIFTICVIFKREKQGSGE 
APTRVNTEIRSSYQSIETKDRKFTYSEILKMTNNFERVLGKGGYGRVYYGKLDDTEVAVK 
MLFHSSAEQDYKHFKAEVELLLRVHHRHLVGLVGYCDDGDNFALIYEYMANGDLKENMSG 
NRSGHVLSWENRMQIAMEAAQGLEYLHNGSRPPMVHRDVKTTNILLNELYQAKLADFGLS 
RSSPVDGESYVSTIVAGTPGYLDPETNLLSEKTDVYSFGVVLLEIITNQPVIDTTREKAH 
ITDWVGFKLMEGDIRNIIDPKLIKEFDTNGVWKAVELALSCVNPTSNHRPTMPHVVMELK 
ECLDSEIARKQGSQDMFSRDSIELTFSPTGFSPGPR*
>AT2G19190.1 |  FRK1 (FLG22-INDUCED RECEPTOR-LIKE KINASE 1) kinase 
MAMLKSLSSILFTSFALLFFLVHAQDQSGFISIDCGIPDDSSYNDETTGIKYVSDSAFVD 
SGTTKRIAAQFQSSGFDRHLLNVRSFPQSKRSCYDVPTPRGKGFKYLIRTRFMYGNYDDL 
GRVPEFDLYLGVNFWDSVKLDDATTILNKEIITIPLLDNVQVCVVDKNAGTPFLSVLEIR 
LLLNTTYETPYDALTLLRRLDYSKTGKLPSRYKDDIYDRIWTPRIVSSEYKILNTSLTVD 
QFLNNGYQPASTVMSTAETARNESLYLTLSFRPPDPNAKFYVYMHFAEIEVLKSNQTREF 
SIWLNEDVISPSFKLRYLLTDTFVTPDPVSGITINFSLLQPPGEFVLPPIINALEVYQVN 
EFLQIPTHPQDVDAMRKIKATYRVKKNWQGDPCVPVDYSWEGIDCIQSDNTTNPRVVSLN 
ISFSELRGQIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLTELNVEGNKLTGIVPQ 
RLHERSKNGSLSLRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVVVGIIVVLLTALALFRR 
FKKKQQRGTLGERNGPLKTAKRYFKYSEVVNITNNFERVIGKGGFGKVYHGVINGEQVAV 
KVLSEESAQGYKEFRAEVDLLMRVHHTNLTSLVGYCNEINHMVLIYEYMANENLGDYLAG 
KRSFILSWEERLKISLDAAQGLEYLHNGCKPPIVHRDVKPTNILLNEKLQAKMADFGLSR 
SFSVEGSGQISTVVAGSIGYLDPEYYSTRQMNEKSDVYSLGVVLLEVITGQPAIASSKTE 
KVHISDHVRSILANGDIRGIVDQRLRERYDVGSAWKMSEIALACTEHTSAQRPTMSQVVM 
ELKQIVYGIVTDQENYDDSTKMLTVNLDTEMVPRAR*
>AT1G51880.1 |  leucine-rich repeat protein kinase putative 
MKSIHGFLLFLITAYVILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYID 
SGLVGRISAEYKAQLQQQTWTVRSFPEGERNCYNFNLTAKSRYLIRATFTYGNYDGLRQV 
PKFDIHIGPSKWTSVKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLN 
NNTYLTQSGSLIGFARVFFSATPTFIRYDEDIHDRVWVRQFGNGLKSISTDLLVDTSNPY 
DVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNITYNGG 
QNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLINGLEIYKVLDLLEL 
ETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSDQPRIISLNLAEN 
KLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLIKLNVFICRNLSGNLGLN 
STIPDSIQQRLDSKSLILILSKTVTKTVTLKGKSKKVPMIPIVASVAGVFALLVILAIFF 
VVRRKNGESNKGTNPSIITKERRITYPEVLKMTNNFERVLGKGGFGTVYHGNLEDTQVAV 
KMLSHSSAQGYKEFKAEVELLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSG 
KRGGNVLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLS 
RSFPVDGESHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTRE 
RTHINEWVGSMLTKGDIKSILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVT 
ELNECVALENARRQGREEMHTSGYVDFSRSSASEFSPGAR*
>AT4G29990.1 |  light repressible receptor protein kinase 
MTRLRLLSWISITSCVCLVFAQDQSGFISIDCGIPDDSSYTDEKTNMKYVSDLGFVESGT 
SHSIVSDLQTTSLERQFQNVRSFPEGKRNCYDIRPQQGKGFKYLIRTRFMYGNYDGFSKT 
PEFDLYIGANLWESVVLINETAIMTKEIIYTPPSDHIHVCLVDKNRGTPFLSVLEIRFLK 
NDTYDTPYEALMLGRRWDFGTATNLQIRYKDDFYDRIWMPYKSPYQKTLNTSLTIDETNH 
NGFRPASIVMRSAIAPGNESNPLKFNWAPDDPRSKFYIYMHFAEVRELQRNETREFDIYI 
NDVILAENFRPFYLFTDTRSTVDPVGRKMNEIVLQRTGVSTLPPIINAIEIYQINEFLQL 
PTDQQDVDAMTKIKFKYRVKKNWQGDPCVPVDNSWEGLECLHSDNNTSPKSIALNLSSSG 
LTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGSIPAKLLEK 
SKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAGLLIVLTALALIWHFKKRS 
RRGTISNKPLGVNTGPLDTAKRYFIYSEVVNITNNFERVLGKGGFGKVYHGFLNGDQVAV 
KILSEESTQGYKEFRAEVELLMRVHHTNLTSLIGYCNEDNHMALIYEYMANGNLGDYLSG 
KSSLILSWEERLQISLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADFGLSR 
SFPVEGSSQVSTVVAGTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVITGKPAIWHSRTE 
SVHLSDQVGSMLANGDIKGIVDQRLGDRFEVGSAWKITELALACASESSEQRPTMSQVVM 
ELKQSIFGRVNNRSDHKDPVRMVTMNLDTEMVPRAR*
>AT1G51800.1 |  leucine-rich repeat protein kinase putative 
MAFSSCFLLVLLQIFSALLLCLAQDQSGFISLDCGSPRETSFREKTTNITYISDANFINT 
GVGGSIKQGYRTQFQQQTWNLRSFPQGIRNCYTLNLTIGDEYLIRANFLHGGYDDKPSTQ 
FELYLGPNLWSTVTTTNETEASIFEMIHILTTDRLQICLVKTGNATPFISALELRKLMNT 
TYLTRQGSLQTFIRADVGATVNQGYRYGIDVFDRVWTPYNFGNWSQISTNQSVNINNDYQ 
PPEIAMVTASVPTDPDAAMNISLVGVERTVQFYVFMHFAEIQELKSNDTREFNIMYNNKH 
IYGPFRPLNFTTSSVFTPTEVVADANGQYIFSLQRTGNSTLPPLLNAMEIYSVNLLPQQE 
TDRKEVDAMMNIKSAYGVNKIDWEGDPCVPLDYKWSGVNCTYVDNETPKIISLDLSTSGL 
TGEILEFISDLTSLEVLDLSNNSLTGSVPEFLANMETLKLINLSGNELNGSIPATLLDKE 
RRGSITLSIEGNTGLCSSTSCATTKKKKKNTVIAPVAASLVSVFLIGAGIVTFLILKRKK 
RTKLGLNPNSGTGTTPLHSRSHHGFEPPVIAKNRKLTYIDVVKITNNFERVLGRGGFGVV 
YYGVLNNEPVAVKMLTESTALGYKQFKAEVELLLRVHHKDLTCLVGYCEEGDKMSLIYEF 
MANGDLKEHLSGKRGPSILTWEGRLRIAAESAQGLEYLHNGCKPQIVHRDIKTTNILLNE 
KFQAKLADFGLSRSFPLGTETHVSTIVAGTPGYLDPEYYRTNWLTEKSDVFSFGVVLLEL 
VTNQPVIDMKREKSHIAEWVGLMLSRGDINSIVDPKLQGDFDPNTIWKVVETAMTCLNPS 
SSRRPTMTQVVMDLKECLNMEMARNMGSRMTDSTNDSSIELSMNFTTELNPGAR*
>AT1G51890.1 |  leucine-rich repeat protein kinase putative 
MRFLSFLIFVFAVLGLVQAQDQSGFISLDCGLVPTEITYVEKSTNITYRSDATYIDSGVP 
GKINEVYRTQFQQQIWALRSFPEGQRNCYNFSLTAKRKYLIRGTFIYGNYDGLNQLPSFD 
LYIGPNKWTSVSIPGVRNGSVSEMIHVLRQDHLQICLVKTGETTPFISSLELRPLNNNTY 
VTKSGSLIVVARLYFSPTPPFLRYDEDVHDRIWIPFLDNKNSLLSTELSVDTSNFYNVPQ 
TVAKTAAVPLNATQPLKINWSLDDITSQSYIYMHFAEIENLEANETREFNITYNGGENWF 
SYFRPPKFRITTVYNPAAVSSLDGNFNFTFSMTGNSTHPPLINGLEIYQVLELPQLDTYQ 
DEVSAMMNIKTIYGLSKRSSWQGDPCAPELYRWEVLTFGLSIRNLSGSNLSGTITSDISK 
LTHLRELDLSNNDLSGDIPFVFSDMKNLTLINLSGNKNLNRSVPETLQKRIDNKSLTLIR 
DETGKNSTNVVAIAASVASVFAVLVILAIVFVVIRKKQRTNEGPRSFTTGTVKSDARSSS 
SSIITKERKFTYSEVLKMTKNFERVLGKGGFGTVYHGNLDDTQVAVKMLSHSSAQGYKEF 
KAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMEKGDLRENMSGKHFNLVESISLDSL 
KHSKPGTGKHSVNVLSWETRMQIAVEAAQGLEYLHNGCRPPMVHRDVKPTNILLNERSQA 
KLADFGLSRSFPVDGESHVMTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQ 
PVMNKNRERPHINEWVMFMLTNGDIKSIVDPKLNEDYDTNGVWKVVELALACVNPSSSRR 
PTMPHVVMELNECLALEIERKQGSQATYIKESVEFSPSSASDFSPLAR*
>AT1G51870.1 |  protein kinase family protein 
MKSLHFCLLFMIVSFTVSRPVEAQDQAGFISLDCGLVPKETTYVETSTNITYKSDANYTD 
SGLVGKINDAHKTLVQQPLWALRSFPEGERNCYNFNLTVNSTYLIRGTFLYGNYDGLNQS 
PSFDLHIGASKWTSVNIVGVTDTVMPEIIHVLTQKRLQVCLVKTGKTTPFISSLELRPLI 
NNIYIAESGSMVLQNRVYFPSDSTSIVRYDEDIHDRVWNPVSDDDSSSISTDLQVQTNNL 
YDVPQFVMKTAAIPKDASAPWSLVWTIDNTTALSYVYMHFAEIQDLKANDLREFDITYNG 
GKLWFSQFRPNKLSILTMFSQVPLTSSNGEYNFTFEMTSNSTLPPLINALEIYTGLEILQ 
LQTDKDEVSAMMNIKTTYDLSKKISWQGDPCAPQLYRWEGLDCSYPDTEASRIISLNLNA 
SGLNGTITSDITKLTQLSELLGEKVKMNPTAKKESKKVPIVPIAASVAGVFALIVILAIF 
FIVKGKKGKSAEGPPLSVTSGTAKSETRSSNPSIMRKDRKITYPQVLKMTNNFERVLGKG 
GFGTVYHGNMEDAQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLA 
LIYEYMANGDLRENMLGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTN 
ILLNAQCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGV 
VLLEIVTNQPVINQTRERPHINEWVGFMLSKGDIKSIVDPKLMGDYDTNGAWKIVELGLA 
CVNPSSNLRPTMAHVVIELNECVAFENARRQGSEEMYTRSSTNFSHTSASEFSPGAR*
>AT5G16750.1 |  TOZ (TORMOZEMBRYO DEFECTIVE) nucleotide binding 
MAPHSLKKNYRCSRSLKQFYGGGPFIVSSDGSFIACACGDVINIVDSTDSSVKSTIEGES 
DTLTALALSPDDKLLFSAGHSRQIRVWDLETLKCIRSWKGHEGPVMGMACHASGGLLATA 
GADRKVLVWDVDGGFCTHYFRGHKGVVSSILFHPDSNKNILISGSDDATVRVWDLNAKNT 
EKKCLAIMEKHFSAVTSIALSEDGLTLFSAGRDKVVNLWDLHDYSCKATVATYEVLEAVT 
TVSSGTPFASFVASLDQKKSKKKESDSQATYFITVGERGVVRIWKSEGSICLYEQKSSDI 
TVSSDDEESKRGFTAAAMLPSDHGLLCVTADQQFFFYSVVENVEETELVLSKRLVGYNEE 
IADMKFLGDEEQFLAVATNLEEVRVYDVATMSCSYVLAGHKEVVLSLDTCVSSSGNVLIV 
TGSKDKTVRLWNATSKSCIGVGTGHNGDILAVAFAKKSFSFFVSGSGDRTLKVWSLDGIS 
EDSEEPINLKTRSVVAAHDKDINSVAVARNDSLVCTGSEDRTASIWRLPDLVHVVTLKGH 
KRRIFSVEFSTVDQCVMTASGDKTVKIWAISDGSCLKTFEGHTSSVLRASFITDGTQFVS 
CGADGLLKLWNVNTSECIATYDQHEDKVWALAVGKKTEMIATGGGDAVINLWHDSTASDK 
EDDFRKEEEAILRGQELENAVLDAEYTKAIRLAFELCRPHKVFELFSGLCRKRDSDEQIV 
KALQGLEKEEFRLLFEYVREWNTKPKLCHIAQFVLYKTFNILPPTEIVQVKGIGELLEGL 
IPYSQRHFSRIDRFVRSSFLLDYTLGEMSVIDPETVETEYPKDEKKKEKDVIAAMEQDTD 
ELKQETPSRKRKSQKSKGKSNKKRLIAEAQGSVIAV*